rs375375478

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS1

The NM_005219.5(DIAPH1):​c.2358+15C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000915 in 1,321,998 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00038 ( 0 hom., cov: 28)
Exomes 𝑓: 0.000055 ( 0 hom. )

Consequence

DIAPH1
NM_005219.5 intron

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.333

Publications

0 publications found
Variant links:
Genes affected
DIAPH1 (HGNC:2876): (diaphanous related formin 1) This gene is a homolog of the Drosophila diaphanous gene, and has been linked to autosomal dominant, fully penetrant, nonsyndromic sensorineural progressive low-frequency hearing loss. Actin polymerization involves proteins known to interact with diaphanous protein in Drosophila and mouse. It has therefore been speculated that this gene may have a role in the regulation of actin polymerization in hair cells of the inner ear. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
DIAPH1 Gene-Disease associations (from GenCC):
  • DIAPH1-related sensorineural hearing loss-thrombocytopenia syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • autosomal dominant nonsyndromic hearing loss 1
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia
  • progressive microcephaly-seizures-cortical blindness-developmental delay syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 5-141573477-G-C is Benign according to our data. Variant chr5-141573477-G-C is described in ClinVar as Likely_benign. ClinVar VariationId is 227302.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAdExome4 allele frequency = 0.0000554 (65/1173456) while in subpopulation AFR AF = 0.00186 (50/26924). AF 95% confidence interval is 0.00145. There are 0 homozygotes in GnomAdExome4. There are 29 alleles in the male GnomAdExome4 subpopulation. Median coverage is 38. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DIAPH1NM_005219.5 linkc.2358+15C>G intron_variant Intron 16 of 27 ENST00000389054.8 NP_005210.3 O60610-1Q6URC4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DIAPH1ENST00000389054.8 linkc.2358+15C>G intron_variant Intron 16 of 27 5 NM_005219.5 ENSP00000373706.4 O60610-1
DIAPH1ENST00000518047.5 linkc.2331+15C>G intron_variant Intron 15 of 26 5 ENSP00000428268.2 O60610-3
DIAPH1ENST00000647433.1 linkc.2358+15C>G intron_variant Intron 16 of 28 ENSP00000494675.1 A0A2R8Y5N1

Frequencies

GnomAD3 genomes
AF:
0.000377
AC:
56
AN:
148454
Hom.:
0
Cov.:
28
show subpopulations
Gnomad AFR
AF:
0.00127
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000201
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000981
GnomAD2 exomes
AF:
0.0000742
AC:
18
AN:
242530
AF XY:
0.0000453
show subpopulations
Gnomad AFR exome
AF:
0.00108
Gnomad AMR exome
AF:
0.0000581
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000554
AC:
65
AN:
1173456
Hom.:
0
Cov.:
38
AF XY:
0.0000489
AC XY:
29
AN XY:
593456
show subpopulations
African (AFR)
AF:
0.00186
AC:
50
AN:
26924
American (AMR)
AF:
0.0000935
AC:
4
AN:
42776
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
22552
East Asian (EAS)
AF:
0.0000290
AC:
1
AN:
34512
South Asian (SAS)
AF:
0.00
AC:
0
AN:
80938
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49676
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3684
European-Non Finnish (NFE)
AF:
0.00000348
AC:
3
AN:
863252
Other (OTH)
AF:
0.000142
AC:
7
AN:
49142
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
3
7
10
14
17
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000377
AC:
56
AN:
148542
Hom.:
0
Cov.:
28
AF XY:
0.000276
AC XY:
20
AN XY:
72460
show subpopulations
African (AFR)
AF:
0.00126
AC:
51
AN:
40338
American (AMR)
AF:
0.000201
AC:
3
AN:
14934
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3426
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5032
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4642
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9938
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
282
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
66998
Other (OTH)
AF:
0.000973
AC:
2
AN:
2056
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.515
Heterozygous variant carriers
0
4
7
11
14
18
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000142
Hom.:
0
Bravo
AF:
0.000442

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Apr 30, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

2358+15C>G in Intron 16 of DIAPH1: This variant is not expected to have clinical significance because it is not located within the conserved splice consensus se quence and has been identified in 0.1% (4/2940) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http://evs.gs.was hington.edu/EVS). -

Autosomal dominant nonsyndromic hearing loss 1;C5567650:Progressive microcephaly-seizures-cortical blindness-developmental delay syndrome Benign:1
Jan 07, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
10
DANN
Benign
0.58
PhyloP100
-0.33

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs375375478; hg19: chr5-140953044; API